Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Fulvio Braido"'
Autor:
Fulvio Braido, Giovanni Melioli, Gabriele Nicolini, Melissa Ferraris, Stefano Di Girolamo, Mario Di Gioacchino, Giorgio Walter Canonica
Publikováno v:
Drugs in Context, Vol 13, Pp 1-9 (2024)
This review discusses available evidence on the mechanisms of action of bacterial lysates, and the clinical effects of their sublingual administration. Bacterial lysates act through many immunological effects, including dendritic cell activation, mod
Externí odkaz:
https://doaj.org/article/8adfed43c71d4e2099a725fb93d48d3b
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0292980 (2024)
Explainable Artificial Intelligence (XAI) is becoming a disruptive trend in healthcare, allowing for transparency and interpretability of autonomous decision-making. In this study, we present an innovative application of a rule-based classification m
Externí odkaz:
https://doaj.org/article/9361d6009af44284ad846ab4df1a5337
Autor:
Andrew Smith, Peter Kardos, Oliver Pfaar, Winfried Randerath, Guillermo Estrada Riolobos, Fulvio Braido, Laura Sadofsky
Publikováno v:
Drugs in Context, Vol 12, Pp 1-15 (2023)
Following the waning severity of COVID-19 due to vaccination and the development of immunity, the current variants of SARS-CoV-2 often lead to mild upper respiratory tract infections (MURTIs), suggesting it is an appropriate time to review the pathog
Externí odkaz:
https://doaj.org/article/c693e651f04d4cdf9957c1d995bdf99c
Autor:
Diego Bagnasco, Laura De Ferrari, Benedetta Bondi, Maria Giulia Candeliere, Marcello Mincarini, Anna Maria Riccio, Fulvio Braido
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 5972 (2024)
Thymic stromal lymphopoietin (TSLP), is a protein belonging to a class of epithelial cytokines commonly called alarmins, which also includes IL-25 and IL-33. Functionally, TSLP is a key player in the immune response to environmental insults, initiati
Externí odkaz:
https://doaj.org/article/81a7228dec684a3b9ac8d5f26ea5f1a2
Autor:
Laura Pini, Diego Bagnasco, Bianca Beghè, Fulvio Braido, Paolo Cameli, Marco Caminati, Cristiano Caruso, Claudia Crimi, Gabriella Guarnieri, Manuela Latorre, Francesco Menzella, Claudio Micheletto, Andrea Vianello, Dina Visca, Benedetta Bondi, Yehia El Masri, Jordan Giordani, Andrea Mastrototaro, Matteo Maule, Alessandro Pini, Stefano Piras, Martina Zappa, Gianenrico Senna, Antonio Spanevello, Pierluigi Paggiaro, Francesco Blasi, Giorgio Walter Canonica, on behalf of the SANI Study Group
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 10, p 3013 (2024)
Background: Benralizumab has been shown to restore good control of severe eosinophilic asthma (SEA). Robust data on benralizumab effectiveness over periods longer than 2 years are scarce. Methods: This retrospective multicentric study was conducted o
Externí odkaz:
https://doaj.org/article/2a5397c1b8144023b9fc291eadfa6b08
Autor:
Diego Bagnasco, Benedetta Bondi, Marco Caminati, Stefania Nicola, Laura Pini, Manlio Milanese, Luisa Brussino, Gianenrico Senna, Giorgio Walter Canonica, Fulvio Braido
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 960 (2024)
Background: In its severe form, where possible, asthma is treated using biological drugs in order to reduce, as much as possible, the use of systemic steroids. Mepolizumab is effective for severe asthma based on key outcomes such as exacerbation and
Externí odkaz:
https://doaj.org/article/3d265a7a68614149aea5944e49d79a90
Autor:
Marco Caminati, Matteo Maule, Roberto Benoni, Diego Bagnasco, Bianca Beghè, Fulvio Braido, Luisa Brussino, Paolo Cameli, Maria Giulia Candeliere, Giovanna Elisiana Carpagnano, Giulia Costanzo, Claudia Crimi, Mariella D’Amato, Stefano Del Giacco, Gabriella Guarnieri, Mona-Rita Yacoub, Claudio Micheletto, Stefania Nicola, Bianca Olivieri, Laura Pini, Michele Schiappoli, Rachele Vaia, Andrea Vianello, Dina Visca, Antonio Spanevello, Gianenrico Senna
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 390 (2024)
Dupilumab is currently approved for the treatment of Type 2 severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). Few studies have specifically reported on dupilumab efficacy on asthma outcomes as a primary objective in a real-life set
Externí odkaz:
https://doaj.org/article/3daaf0d88d9b489b9717495e5066b45f
Autor:
Diego Bagnasco, Edoardo Vincenzo Savarino, Mona-Rita Yacoub, Fulvio Braido, Maria Giulia Candeliere, Edoardo Giannini, Giovanni Passalacqua, Elisa Marabotto
Publikováno v:
Pharmaceutics, Vol 15, Iss 9, p 2359 (2023)
The role of type 2 inflammation has been progressively associated with many diseases, including severe asthma, atopic dermatitis, nasal polyposis, eosinophilic granulomatosis with polyangiitis, and, recently, eosinophilic esophagitis. Despite this, t
Externí odkaz:
https://doaj.org/article/f806ffb12c9c4743bbf937131b1ec0b8
Autor:
Jean Bousquet, Josep M. Anto, Bernardo Sousa‐Pinto, Wienczyslawa Czarlewski, Anna Bedbrook, Tari Haahtela, Ludger Klimek, Oliver Pfaar, Piotr Kuna, Maciej Kupczyk, Frederico S. Regateiro, Boleslaw Samolinski, Arunas Valiulis, Arzu Yorgancioglu, Sylvie Arnavielhe, Xavier Basagaña, Karl C. Bergmann, Sinthia Bosnic‐Anticevich, Luisa Brussino, G. Walter Canonica, Victoria Cardona, Lorenzo Cecchi, Claudia Chaves‐Loureiro, Elisio Costa, Alvaro A. Cruz, Bilun Gemicioglu, Wytske J. Fokkens, Juan Carlos Ivancevich, Helga Kraxner, Violeta Kvedariene, Désirée E. Larenas‐Linnemann, Daniel Laune, Renaud Louis, Michael Makris, Marcus Maurer, Erik Melén, Yann Micheli, Mario Morais‐Almeida, Joaquim Mullol, Marek Niedoszytko, Yoshitaka Okamoto, Nikolaos G. Papadopoulos, Vincenzo Patella, Nhân Pham‐Thi, Philip W. Rouadi, Joaquin Sastre, Nicola Scichilone, Aziz Sheikh, Mikhail Sofiev, Luis Taborda‐Barata, Sanna Toppila‐Salmi, Ioanna Tsiligianni, Erkka Valovirta, Maria Teresa Ventura, Rafael José Vieira, Mihaela Zidarn, Rita Amaral, Ignacio J. Ansotegui, Annabelle Bédard, Samuel Benveniste, Michael Bewick, Carsten Bindslev‐Jensen, Hubert Blain, Matteo Bonini, Rodolphe Bourret, Fulvio Braido, Pedro Carreiro‐Martins, Denis Charpin, Ivan Cherrez‐Ojeda, Tomas Chivato, Derek K. Chu, Cemal Cingi, Stefano DelGiacco, Frédéric deBlay, Philippe Devillier, Govert DeVries, Maria Doulaptsi, Virginie Doyen, Gérard Dray, Jean‐François Fontaine, R. Maximiliano Gomez, Jan Hagemann, Enrico Heffler, Maja Hofmann, Ewa Jassem, Marek Jutel, Thomas Keil, Vicky Kritikos, Inger Kull, Marek Kulus, Olga Lourenço, Eve Mathieu‐Dupas, Enrica Menditto, Ralph Mösges, Ruth Murray, Rachel Nadif, Hugo Neffen, Stefania Nicola, Robyn O’Hehir, Heidi Olze, Yuliia Palamarchuk, Jean‐Louis Pépin, Benoit Pétré, Robert Picard, Constantinos Pitsios, Francesca Puggioni, Santiago Quirce, Filip Raciborski, Sietze Reitsma, Nicolas Roche, Monica Rodriguez‐Gonzalez, Jan Romantowski, Ana Sá‐Sousa, Faradiba S. Serpa, Marine Savouré, Mohamed H. Shamji, Milan Sova, Annette Sperl, Cristiana Stellato, Ana Todo‐Bom, Peter Valentin Tomazic, Olivier Vandenplas, Michiel VanEerd, Tuula Vasankari, Frédéric Viart, Susan Waserman, Joao A. Fonseca, Torsten Zuberbier
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 1, Pp n/a-n/a (2023)
Abstract MASK‐air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhin
Externí odkaz:
https://doaj.org/article/7da2b64a9e344f429eb9d0548851bacb
Autor:
Gabriele Rumi, G Walter Canonica, Juliet M Foster, Niels H Chavannes, Giuseppe Valenti, Rosario Contiguglia, Eleni Rapsomaniki, Janwillem W H Kocks, Dario De Brasi, Fulvio Braido
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 11, p e25879 (2022)
BackgroundReliance on short-acting β-2 agonists and nonadherence to maintenance medication are associated with poor clinical outcomes in asthma. Digital health solutions could support optimal medication use and therefore disease control in patients
Externí odkaz:
https://doaj.org/article/7cad15c6a44d43f3845c92325e9788b6